The novel therapy of the medication represents a exciting advance in the management of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide845843.myparisblog.com/42565089/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment